Outcomes of preoperative S-1 and docetaxel combination chemotherapy in patients with locally advanced gastric cancer
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Outcomes of preoperative S-1 and docetaxel combination chemotherapy in patients with locally advanced gastric cancer
Authors
Keywords
Gastric cancer, Preoperative chemotherapy, S-1, Docetaxel
Journal
CANCER CHEMOTHERAPY AND PHARMACOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2019-03-25
DOI
10.1007/s00280-019-03813-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Validity of neoadjuvant chemotherapy with docetaxel, cisplatin, and S-1 for resectable locally advanced gastric cancer
- (2017) Kinro Sasaki et al. MEDICAL ONCOLOGY
- Gastric cancer, nutritional status, and outcome
- (2017) Xuechao Liu et al. OncoTargets and Therapy
- Histological evaluations of primary lesions are independently associated with prognosis in patients with gastric cancer who receive neoadjuvant chemotherapy
- (2017) Tomomitsu Tahara et al. Oncology Letters
- A phase II study of a modified FOLFOX6 regimen as neoadjuvant chemotherapy for locally advanced gastric cancer
- (2016) Xiang Wang et al. BRITISH JOURNAL OF CANCER
- Survival results of a randomised two-by-two factorial phase II trial comparing neoadjuvant chemotherapy with two and four courses of S-1 plus cisplatin (SC) and paclitaxel plus cisplatin (PC) followed by D2 gastrectomy for resectable advanced gastric cancer
- (2016) Takaki Yoshikawa et al. EUROPEAN JOURNAL OF CANCER
- Intraperitoneal chemotherapy for gastric cancer with peritoneal metastasis
- (2016) Daisuke Kobayashi et al. Gastric Cancer
- A phase II study of preoperative chemotherapy with docetaxel, cisplatin, and S-1 followed by gastrectomy with D2 plus para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis: JCOG1002
- (2016) Seiji Ito et al. Gastric Cancer
- Recursive partition analysis of peritoneal and systemic recurrence in patients with gastric cancer who underwent D2 gastrectomy: Implications for neoadjuvant therapy consideration
- (2016) Jee Suk Chang et al. JOURNAL OF SURGICAL ONCOLOGY
- Evaluation of the recurrence pattern of gastric cancer after laparoscopic gastrectomy with D2 lymphadenectomy
- (2016) Yuichiro Kawamura et al. SpringerPlus
- Efficacy of neoadjuvant chemotherapy with docetaxel, cisplatin and S-1 for resectable locally advanced gastric cancer
- (2015) Kazuhiro Migita et al. International Journal of Clinical Oncology
- Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial
- (2015) Joel Shapiro et al. LANCET ONCOLOGY
- Phase II Study of Docetaxel and S-1 (DS) as Neoadjuvant Chemotherapy for Clinical Stage III Resectable Gastric Cancer
- (2014) Eiji Oki et al. ANNALS OF SURGICAL ONCOLOGY
- Prognostic value of histopathological regression in 850 neoadjuvantly treated oesophagogastric adenocarcinomas
- (2014) T Schmidt et al. BRITISH JOURNAL OF CANCER
- Neoadjuvant chemotherapy with S-1 and cisplatin followed by D2 gastrectomy with para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis
- (2014) A. Tsuburaya et al. BRITISH JOURNAL OF SURGERY
- A phase II trial of Xeloda and oxaliplatin (XELOX) neo-adjuvant chemotherapy followed by surgery for advanced gastric cancer patients with para-aortic lymph node metastasis
- (2014) Yan Wang et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Rates and Patterns of Recurrence after Curative Intent Resection for Gastric Cancer: A United States Multi-Institutional Analysis
- (2014) Gaya Spolverato et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- Salvage Gastrectomy After Intravenous and Intraperitoneal Paclitaxel (PTX) Administration with Oral S-1 for Peritoneal Dissemination of Advanced Gastric Cancer with Malignant Ascites
- (2013) Joji Kitayama et al. ANNALS OF SURGICAL ONCOLOGY
- Critical weight loss is a major prognostic indicator for disease-specific survival in patients with head and neck cancer receiving radiotherapy
- (2013) J A E Langius et al. BRITISH JOURNAL OF CANCER
- A phase II study of neoadjuvant combination chemotherapy with docetaxel, cisplatin, and S-1 for locally advanced resectable gastric cancer: nucleotide excision repair (NER) as potential chemoresistance marker
- (2013) Masahiro Hirakawa et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Preoperative S-1 and docetaxel combination chemotherapy in patients with locally advanced gastric cancer
- (2013) Takashi Kosaka et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- A phase II study of neoadjuvant docetaxel, oxaliplatin, and S-1 (DOS) chemotherapy followed by surgery and adjuvant S-1 chemotherapy in potentially resectable gastric or gastroesophageal junction adenocarcinoma
- (2013) Inkeun Park et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Interim endoscopy results during neoadjuvant therapy for gastric cancer correlate with histopathological response and prognosis
- (2013) Ulrike Heger et al. Gastric Cancer
- Validity of response assessment criteria in neoadjuvant chemotherapy for gastric cancer (JCOG0507-A)
- (2013) Yukinori Kurokawa et al. Gastric Cancer
- Phase II study of preoperative chemotherapy with S-1 and cisplatin followed by gastrectomy for clinically resectable type 4 and large type 3 gastric cancers (JCOG0210)
- (2013) Yoshiaki Iwasaki et al. JOURNAL OF SURGICAL ONCOLOGY
- The influence of preoperative weight loss on the postoperative course after esophageal cancer resection
- (2013) Maartje K. van der Schaaf et al. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
- Pathologic and Oncologic Outcomes in Locally Advanced Gastric Cancer with Neoadjuvant Chemotherapy or Chemoradiotherapy
- (2013) Ji Yeong An et al. YONSEI MEDICAL JOURNAL
- Risk Factors for Peritoneal Recurrence in Stage II/III Gastric Cancer Patients Who Received S-1 Adjuvant Chemotherapy After D2 Gastrectomy
- (2011) Toru Aoyama et al. ANNALS OF SURGICAL ONCOLOGY
- Posttherapy Nodal Status, Not Graded Histologic Response, Predicts Survival after Neoadjuvant Chemotherapy for Advanced Gastric Cancer
- (2011) Kazumasa Fujitani et al. ANNALS OF SURGICAL ONCOLOGY
- Japanese classification of gastric carcinoma: 3rd English edition
- (2011) Gastric Cancer
- Five-Year Outcomes of a Randomized Phase III Trial Comparing Adjuvant Chemotherapy With S-1 Versus Surgery Alone in Stage II or III Gastric Cancer
- (2011) Mitsuru Sasako et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy of pre-operative chemotherapy with docetaxel, cisplatin, and S-1 (DCS therapy) and curative resection for gastric cancer with pathologically positive para-aortic lymph nodes
- (2011) Katsunobu Oyama et al. JOURNAL OF SURGICAL ONCOLOGY
- Definition and classification of cancer cachexia: an international consensus
- (2011) Kenneth Fearon et al. LANCET ONCOLOGY
- Cachexia: A new definition
- (2008) William J. Evans et al. CLINICAL NUTRITION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started